Bosutinib (Bosulif) - Oncology Nurse Advisor
Skip to navigation Skip to main content

Bosutinib (Bosulif)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews bosutinib (Bosulif), indicated for the treatment of chronic, accelerated, or blast phase Philadelphia chromosome (Ph)-positive chronic myeloid leukemia (CML) with resistance or intolerance to prior therapy.

Table of Contents

Slide 4: Dosage and Administration
Slide 11: Cautions, Effects, and Interactions
Slide 18: What to Tell Your Patient
Slide 27: Reference

Topics:

Drug Information Slideshows Stat Consult
Next hm-slideshow in Slides